4Benchenane K, Berezowski V, Ali C, et al. Tissue-type plasminogen activator crosses the intact blood-brain bamer by low-density lipoprotein receptor related protein-mediated transcytosis. Circulation, 2005, 111 ( 17): 2241-2249.
5Nogueira RG, Schwamm LH, Hirsch JA. Endovascular approaches to acute stroke. Part 1. Drugs, devices, and data. AJNR, 2009, 30 (4): 649-661.
6Rauen U, Li T, Ioannidis I, et al. Nitric oxide increases toxicity of hydrogen peroxide against rat liver endothelial cells and hepatocytes by inhibition of hydrogen peroxide degradation. Am J Physiol Cell Physiol, 2007, 292 (4): C1440-C1449.
7Simmons WL, Rivera KE, Curiel DT, et al. Adenovirally mediated gene transfer of functional human tissue-type plasminogen activator to murine lungs. Am J Respir Cell Mol Biol, 1998, 18 (3): 307-314.
9Pahlman Ll, Marx PF, Morgelin M, et al. Thrombin-activatable fibrinolysis inhibitor binds to Streptococcus pyogenes by interacting with collagen-like proteins A and B. J Biol Chem, 2007, 282 (34) : 24873-24881.
10Liu YX, Liu K, Feng Q, et al. Tissue-type plasminogen activator and its inhibitor plasminogen activator inhibitor type 1 are coordinately expressed during ovulation in the rhesus monkey. Endocrinology, 2004,145 (4): 1767-1775.
